FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial 1 Foundayo, Lilly's second FDA-approved obesity medicine, will be available via LillyDirect with free home delivery, starting at , with prescriptions accepted immediately and shipping beginning "People living with obesity need treatment options that meet them where they are and for many, a once-daily pill that can be taken with no food or water restrictions can offer them greater flexibility in how they approach their treatment," said Supported by the rigorous ATTAIN clinical trial program, Foundayo was proven to help people lose weight and keep it off
Additionally growth hormone-releasing peptides (GHRPs) like Sermorelin are known for their ability to enhance fat metabolism and promote lean muscle mass
Semaglutide and liraglutide have been used for years with reassuring safety profiles
It is FDA-approved exclusively for type 2 diabetes (under the brand name Mounjaro) and chronic weight management in adults with obesity or overweight plus weight-related comorbidities (under the brand name Zepbound)
Sleep on purpose Short or poor-quality sleep increases hunger hormones and encourages fat storage to accumulate in the abdomen